Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4377 |
Pimodivir
VX-787 |
Influenza Virus | Microbiology/Virology |
Pimodivir (VX-787) 是一种通过口服的甲型流感病毒聚合酶抑制剂,与病毒 PB2 亚基相互作用。 | |||
T70207 |
Pimodivir tosylate
|
||
Pimodivir, also known as VX-787, JNJ-872, is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. VX-787 binds the cap-binding domain of the PB2 subunit with a KD (dissociation constant) of 24 nM as determined by isothermal titration calorimetry (ITC). The cell-based EC50 (the concentration of compound that ensures 50% cell viability of an uninfected control) for VX-787 is 1.6 nM in a cytopathic effect (CPE) assay... | |||
T4377L |
Pimodivir HCl
Pimodivir hydrochloride hemihydrate,Pimodivir hydrochloride |
||
Pimodivir is an inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. The cell-based EC50 for VX-787 is 1.6 nM in a cytopathic effect (CPE) assay. VX-787 is active against a diverse |